story of the week
Zalutumumab Plus Best Supportive Care Beneficial In SCCHN
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology